Product Program year 2025 Source: CMS Open Payments

Surgimend

Device Recon-Skin And Wound

PDI 10381780357391

Open in the dashboard

General payments

$854,279

10,667 payments

Research payments

$50,374

4 payments

Through program year 2025, $854,279 in general payments and $50,374 in research payments were reported against Surgimend (Recon-Skin And Wound).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $270,922 3,047
2024 General $216,609 2,389
2024 Research $15,250 1
2023 General $131,669 1,890
2023 Research $20,604 2
2022 General $93,380 2,046
2022 Research $14,520 1
2021 General $141,699 1,295

Breakdown

Who paid General payments · program years 2021–2025
  1. Integra LifeSciences Corporation $854,279 10,667 payments
Top recipients General payments · program year 2025
  1. Suhail Kanchwala Plastic Surgery · Philadelphia, PA $29,255 11% · 14 payments
  2. Dino Ravnic Plastic Surgery · Hershey, PA $12,516 5% · 17 payments
  3. Said Azoury Surgery · Philadelphia, PA $8,401 3% · 8 payments
  4. Kenneth Fan Plastic Surgery · Washington, DC $7,259 3% · 5 payments
  5. Warren Ellsworth Plastic Surgery · Houston, TX $6,561 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Plastic Surgery $125,255 48% · 494 practitioners
  2. Plastic and Reconstructive Surgery Surgery $54,970 21% · 305 practitioners
  3. Surgery $39,426 15% · 334 practitioners
  4. Physician Assistant, Surgical Physician Assistant $5,037 2% · 57 practitioners
  5. Physician Assistant $4,511 2% · 103 practitioners

The top 5 of 74 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $60,463 22% · 73 recipients
  2. Florida $28,570 11% · 191 recipients
  3. California $23,812 9% · 190 recipients
  4. Texas $22,982 8% · 194 recipients
  5. Ohio $13,310 5% · 97 recipients

The top 5 of 46 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

10,667 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record